Publication | Closed Access
LncRNA PRAL is closely related to clinical prognosis of multiple myeloma and the bortezomib sensitivity
23
Citations
35
References
2018
Year
Hematological MalignancyOncologyMedicinePathologyBortezomib SensitivityMultiple MyelomaLong Non-coding RnaMolecular DiagnosticsCell BiologyLncrna PralCancer Research
| Year | Citations | |
|---|---|---|
Page 1
Page 1